Qscheck Uisacr
Enzymatic Method, Creatinine. 510(k) K252619, from Qstag, Inc. (Incheon, KR). Product code JFY, class 2.
As of Nov 20, 2026, K252619 is an FDA 510(k) held by Qstag, Inc., substantially equivalent on Feb 20, 2026 after 185 days, with no recalls tied to it in FDA's recall database.
- Review time: 185 days
- Recalls: 0
QSCHECK UISACR is intended for the in vitro semi-quantitative measurement of the following parameters: microalbumin and creatinine in urine specimens and for Albumin/Creatinine ratio (ACR) calculated using those values. The results may be used in conjunction with clinical evaluation as an aid in the assessment for kidney function. The system is intended for
- ACR LAB Urine Analysis Test SystemK182384 · Healthy.Io, Ltd. · Jul 26, 2019
- Atellica CH Enzymatic Creatinine_3 (ECre3)K212223 · Siemens Healthcare Diagnostics, Inc. · Nov 24, 2021
- Yumizen C1200 Creatinine PAPK193649 · Horiba Abx SAS · May 10, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Aug 19, 2025
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1225
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files